← Back to Search

Patient Empowerment Program for Prostate Cancer (PC-PEP Trial)

N/A
Recruiting
Research Sponsored by Nova Scotia Health Authority
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age >18
History of a prostate cancer diagnosis
Must not have
Men with a predicted survival less than 2 years.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 - 24 months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to improve the quality of life for men with prostate cancer by testing a comprehensive intervention called the Prostate Cancer Patient Empowerment Program (PC-PEP).

Who is the study for?
This trial is for men over 18 with prostate cancer who can exercise moderately, use email and the internet, understand English, and are expected to live more than 2 years. They must be able to fill out surveys and watch videos online. Men unfit for low-level exercise or without internet access cannot join.
What is being tested?
The Prostate Cancer Patient Empowerment Program (PC-PEP) is being tested on 400 men to improve their mental health, fitness levels, quality of life, and reduce side effects from treatments like surgery or radiation therapy.
What are the potential side effects?
Since this program focuses on education and lifestyle changes rather than medication or medical procedures, it may not have typical clinical trial side effects but could include muscle soreness from increased physical activity.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am older than 18 years.
Select...
I have been diagnosed with prostate cancer.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My doctor expects I have less than 2 years to live.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 - 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 - 24 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Mental Health
Secondary study objectives
Diet as assessed by the Starting the Conversation (STC) Questionnaire
Disease Specific Health-Related Quality of Life as assessed by the Functional Assessment of Cancer Therapy-Prostate (FACT-P)
General Health (Physical and Mental) Quality of Life as assessed by the 12-item Short Form Health Survey (SF-12)
+5 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Intervention ArmExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Nova Scotia Health AuthorityLead Sponsor
288 Previous Clinical Trials
94,062 Total Patients Enrolled
4 Trials studying Prostate Cancer
328 Patients Enrolled for Prostate Cancer

Media Library

Patient Empowerment Program Clinical Trial Eligibility Overview. Trial Name: NCT04895839 — N/A
Prostate Cancer Research Study Groups: Intervention Arm
Prostate Cancer Clinical Trial 2023: Patient Empowerment Program Highlights & Side Effects. Trial Name: NCT04895839 — N/A
Patient Empowerment Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT04895839 — N/A
~104 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top